Dermapharm Holding SE

Price Chart

Risk-Adjusted Performance

Also Listed On

Dermapharm Holding SE (DMPHF) Price Performance

Dermapharm Holding SE (DMPHF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $39.56.

Over the past year, DMPHF has traded between a low of $37.56 and a high of $39.56. The stock has gained 5.3% over this period. It is currently 5.3% above its 52-week low.

Dermapharm Holding SE has a market capitalization of $2.13B, with a price-to-earnings ratio of 17.90 and a dividend yield of 2.28%.

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Compare Dermapharm Holding SE

Side-by-side comparison against top Healthcare peers.